| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |